Rethinking Institutional Entrepreneurship: The Case of the Construction of the Orphan Drug Field in Europe - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Society and Business Review Année : 2014

Rethinking Institutional Entrepreneurship: The Case of the Construction of the Orphan Drug Field in Europe

Julienne Adonajlo Brabet
Karim Hamadache
  • Fonction : Auteur
  • PersonId : 771546
  • IdRef : 178363456

Résumé

Purpose – The purpose of this paper is to enrich empirical studies on institutional entrepreneurship (IE), more specifically those focusing on the role of the IE in building a new field (here the orphan drug [OD] field). This research addresses the main paradoxes of IE theories: a deterministic vs free agent point of view; an individual hero vs a collective action approach; and a change vs reproduction perspective. Design/methodology/approach – A case study of the role of an IE in the building of the OD field in Europe conducted through interviews with the main actors and in-depth documentary research. Findings – The case highlights the IE resources as products of a dynamic historical process driven by values; the process of building the field as an interaction between framing issues, mobilizing agents and resources, transforming a policy window into a political opportunity. It relativizes the IE role: an indispensable catalyst of collective action that can also reinforce the hegemonic bloc while changing the rules. Originality/value – The paper highlights the necessity of longitudinal analysis to address the agent/structure paradox.
Fichier non déposé

Dates et versions

hal-01131732 , version 1 (15-03-2015)

Identifiants

Citer

Julienne Adonajlo Brabet, Karim Hamadache. Rethinking Institutional Entrepreneurship: The Case of the Construction of the Orphan Drug Field in Europe. Society and Business Review, 2014, 9 (2), pp.139-152. ⟨10.1108/SBR-02-2014-0005⟩. ⟨hal-01131732⟩
77 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More